CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 84 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,889,000 | -31.5% | 2,124,975 | 0.0% | 0.07% | -23.9% |
| Q1 2022 | $5,674,000 | -59.2% | 2,124,975 | -33.9% | 0.09% | -48.6% |
| Q4 2021 | $13,919,000 | +50.1% | 3,214,509 | +76.4% | 0.18% | +75.5% |
| Q3 2021 | $9,273,000 | -3.2% | 1,821,868 | +20.4% | 0.10% | +5.2% |
| Q2 2021 | $9,578,000 | – | 1,513,168 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,576,471 | $43,106,000 | 1.62% |
| Altium Capital Management LP | 483,041 | $3,734,000 | 1.04% |
| RA Capital Management | 3,500,000 | $27,055,000 | 0.41% |
| Point72 Asset Management, L.P. | 6,335,000 | $48,970,000 | 0.23% |
| Perceptive Advisors | 2,153,974 | $16,650,000 | 0.21% |
| RTW INVESTMENTS, LP | 1,533,758 | $11,856,000 | 0.18% |
| GLOBEFLEX CAPITAL L P | 115,647 | $894,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 785,899 | $6,075,000 | 0.14% |
| Affinity Asset Advisors, LLC | 50,000 | $387,000 | 0.13% |
| Virtus ETF Advisers LLC | 38,021 | $294,000 | 0.12% |